Literature DB >> 23623567

Extracellular magnesium and calcium reduce myotonia in ClC-1 inhibited rat muscle.

Martin Skov1, Anders Riisager, James A Fraser, Ole B Nielsen, Thomas H Pedersen.   

Abstract

Loss-of-function mutations in the ClC-1 Cl(-) channel trigger skeletal muscle hyperexcitability in myotonia congenita. For reasons that remain unclear, the severity of the myotonic symptoms can vary markedly even among patients with identical ClC-1 mutations, and may become exacerbated during pregnancy and with diuretic treatment. Since both these conditions are associated with hypomagnesemia and hypocalcemia, we explored whether extracellular Mg(2+) and Ca(2+) ([Mg(2+)]o and [Ca(2+)]o) can affect myotonia. Experimental myotonia was induced in isolated rat muscles by ClC-1 inhibition and effects of [Mg(2+)]o or [Ca(2+)]o on myotonic contractions were determined. Both cations dampened myotonia within their physiological concentration ranges. Thus, myotonic contractile activity was 6-fold larger at 0.3 than at 1.2 mM [Mg(2+)]o and 82-fold larger at 0.3 than at 1.27 mM [Ca(2+)]o. In intracellular recordings of action potentials, the threshold for action potential excitation was raised by 4-6 mV when [Mg(2+)]o was elevated from 0.6 to 3 mM, compatible with an increase in the depolarization of the membrane potential necessary to activate the Na(+) channels. Supporting this notion, mathematical simulations showed that myotonia went from appearing with normal Cl(-) channel function to disappearing in the absence of Cl(-) channel function when Na(+) channel activation was depolarized by 6 mV. In conclusion, variation in serum Mg(2+) and Ca(2+) may contribute to phenotypic variation in myotonia congenita patients.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23623567     DOI: 10.1016/j.nmd.2013.03.009

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  14 in total

Review 1.  Guidelines on clinical presentation and management of nondystrophic myotonias.

Authors:  Bas C Stunnenberg; Samantha LoRusso; W David Arnold; Richard J Barohn; Stephen C Cannon; Bertrand Fontaine; Robert C Griggs; Michael G Hanna; Emma Matthews; Giovanni Meola; Valeria A Sansone; Jaya R Trivedi; Baziel G M van Engelen; Savine Vicart; Jeffrey M Statland
Journal:  Muscle Nerve       Date:  2020-05-27       Impact factor: 3.217

Review 2.  Channelopathies of skeletal muscle excitability.

Authors:  Stephen C Cannon
Journal:  Compr Physiol       Date:  2015-04       Impact factor: 9.090

3.  Elevation of extracellular osmolarity improves signs of myotonia congenita in vitro: a preclinical animal study.

Authors:  Kerstin Hoppe; Sunisa Chaiklieng; Frank Lehmann-Horn; Karin Jurkat-Rott; Scott Wearing; Werner Klingler
Journal:  J Physiol       Date:  2018-11-20       Impact factor: 5.182

4.  Coexistence of CLCN1 and SCN4A mutations in one family suffering from myotonia.

Authors:  Lorenzo Maggi; Sabrina Ravaglia; Alessandro Farinato; Raffaella Brugnoni; Concetta Altamura; Paola Imbrici; Diana Conte Camerino; Alessandro Padovani; Renato Mantegazza; Pia Bernasconi; Jean-François Desaphy; Massimiliano Filosto
Journal:  Neurogenetics       Date:  2017-10-09       Impact factor: 2.660

5.  Nanothermometry Reveals Calcium-Induced Remodeling of Myosin.

Authors:  Eric R Kuhn; Akshata R Naik; Brianne E Lewis; Keith M Kokotovich; Meishan Li; Timothy L Stemmler; Lars Larsson; Bhanu P Jena
Journal:  Nano Lett       Date:  2018-10-23       Impact factor: 11.189

6.  Divalent cation-responsive myotonia and muscle paralysis in skeletal muscle sodium channelopathy.

Authors:  Ami Mankodi; Christopher Grunseich; Martin Skov; Lisa Cook; Georg Aue; Enkhtsetseg Purev; Dara Bakar; Tanya Lehky; Karin Jurkat-Rott; Thomas H Pedersen; Richard W Childs
Journal:  Neuromuscul Disord       Date:  2015-08-20       Impact factor: 4.296

Review 7.  ClC-1 chloride channels: state-of-the-art research and future challenges.

Authors:  Paola Imbrici; Concetta Altamura; Mauro Pessia; Renato Mantegazza; Jean-François Desaphy; Diana Conte Camerino
Journal:  Front Cell Neurosci       Date:  2015-04-27       Impact factor: 5.505

8.  Translational approach to address therapy in myotonia permanens due to a new SCN4A mutation.

Authors:  Jean-François Desaphy; Roberta Carbonara; Adele D'Amico; Anna Modoni; Julien Roussel; Paola Imbrici; Serena Pagliarani; Sabrina Lucchiari; Mauro Lo Monaco; Diana Conte Camerino
Journal:  Neurology       Date:  2016-04-29       Impact factor: 9.910

Review 9.  Sodium channel biophysics, late sodium current and genetic arrhythmic syndromes.

Authors:  Karan R Chadda; Kamalan Jeevaratnam; Ming Lei; Christopher L-H Huang
Journal:  Pflugers Arch       Date:  2017-03-06       Impact factor: 3.657

10.  Inhibiting persistent inward sodium currents prevents myotonia.

Authors:  Ahmed A Hawash; Andrew A Voss; Mark M Rich
Journal:  Ann Neurol       Date:  2017-09-18       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.